HGF, HNRPD, and sFLT1 Interfere with the Induction of VEGF in Patients with Severe Psoriasis.
Vladimir V SobolevMadina MuminovaOlga ZhukovaElena DenisovaAnna G SobolevaNikolay PotekaevIrina KorsunskayaAlexander V MezentsevPublished in: Current molecular medicine (2024)
Thus, using VEGF as a biomarker to monitor the disease shall be done cautiously in patients with severe psoriasis.